Effects of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping

被引：0
|
作者：
Lee, Kyung-Yul
Han, Sang Won
Kim, Yong-Jae
Ahn, Seong Hwan
Seo, Woo-Keun
Yu, Sungwook
Oh, Seung-Hun
Kim, Youn Nam
机构：
来源：
STROKE | 2017年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATP411
引用
收藏
页数：2
相关论文
共 50 条
  • [21] In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong
    Chen, Hui
    Zhang, Ya
    Wu, Xiaoying
    Li, Candong
    Wang, Huan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [22] Is 17 α-ethinyl estradiol an inhibitor of cytochrome P450 2C19?
    Rodrigues, AD
    Lu, P
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (03) : 364 - 365
  • [23] Early Recurrent Ischemic Lesion on Diffusion-Weighted MRI Based on the Cytochrome P450 2C19 Genotype in Stroke Patients Treated with Clopidogrel
    Jeong, T.
    Ji, M.
    Kim, S.
    Kim, S.
    Lee, W.
    Kim, H.
    Kwon, S.
    Kang, D.
    Chun, S.
    Min, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 852 - 852
  • [24] Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19
    R Timm
    R Kaiser
    J Lötsch
    U Heider
    O Sezer
    K Weisz
    M Montemurro
    I Roots
    I Cascorbi
    The Pharmacogenomics Journal, 2005, 5 : 365 - 373
  • [25] Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status
    Ikeda, Y
    Umemura, K
    Kondo, K
    Sekiguchi, K
    Nakashima, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (06) : 587 - 588
  • [26] Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
    Zeruesenay Desta
    Xiaojiong Zhao
    Jae-Gook Shin
    David A. Flockhart
    Clinical Pharmacokinetics, 2002, 41 : 913 - 958
  • [27] Cytochrome P450 2C19 Polymorphism in Young Post-Myocardial Infarction Patients Treated With Clopidogrel
    Collet, Jean-Philippe
    Hulot, Jean-Sebastien
    Pena, Ana
    Villard, Eric
    Esteve, Jean-Baptiste
    Silvain, Johanne
    Payot, Laurent
    Cayla, Guillaume
    Beygui, Farzin
    Brugier, Delphine
    Funck-Brentano, Christian
    Montalescot, Gilles
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A344 - A344
  • [28] Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    F Sofi
    B Giusti
    R Marcucci
    A M Gori
    R Abbate
    G F Gensini
    The Pharmacogenomics Journal, 2011, 11 : 199 - 206
  • [29] Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
    Gyu-Hyeong Lee
    Vitchan Kim
    Sung-Gyu Lee
    Eunseo Jeong
    Changmin Kim
    Yoo-Bin Lee
    Donghak Kim
    Toxicological Research, 2024, 40 : 215 - 222
  • [30] Cytochrome P450 2C19☆2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    Sofi, F.
    Giusti, B.
    Marcucci, R.
    Gori, A. M.
    Abbate, R.
    Gensini, G. F.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (03): : 199 - 206
12345